SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures
DAVE 186.25+2.2%12:17 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ~digs who wrote (1196)7/14/2005 6:24:22 PM
From: ~digs  Read Replies (2) of 7944
 
VSNI.ob 1.2
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
Viseon, Inc. engages in the development, manufacture, and resale of desktop and consumer video communications systems. The company provides VisiFone, a personal broadband video communication device that operates on various broadband connections, including high-speed Internet connections via digital subscriber lines or cable modem, and is compatible with both home and office networks. It offers videoconferencing systems primarily to corporate and government-related end users, and OEM customers.

ENMD 2.75
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
EntreMed, Inc., a clinical-stage biopharmaceutical company, develops therapeutic candidates primarily for the treatment of cancer. As of June 16, 2004, Panzem, its lead drug candidate, was in clinical trials for cancer, as well as in discovery and preclinical development for indications outside of oncology. It is a naturally occurring estrogen metabolite; has multiple mechanisms of action; inhibits angiogenesis, microtubule formation, HIF-1a and osteoclastic activity; and induces apoptosis (cell death). In addition, the company designs new chemical compounds to inhibit tumor growth and angiogenesis activities. Specifically, it modifies the chemical structure of 2-methoxyestradiol at various positions, as well as synthesizes molecules with combinations of these modifications. Further, EntreMed’s other therapeutic targets include the proteinase-activated receptor-2, which is a cell surface receptor that activates inflammatory processes, and plays a critical role in tumor growth and formation of new blood vessels in preclinical models; and a peptide fragment of tissue factor pathway inhibitors, a naturally occurring anti-coagulant protein that blocks tumor growth and angiogenesis in in-vivo models.

GRIC 1.65
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
GoRemote Internet Communications, Inc. provides secure managed broadband and remote access solutions to enterprises and service providers worldwide. Its solutions enable enterprises to extend their corporate networks and applications to mobile and remote workers outside the corporate firewall. The company’s integrated managed broadband and remote access services include intelligent client software; multiple network access types, such as broadband, Wi-Fi, and dial-up; security capabilities that ensure security policy compliance by remote workers; a real time remote access management console; end-to-end managed and value added services, such as managed security services; and design, deployment, monitoring, and technical support.

TISA 3.0
stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G
Top Image Systems is a leading innovator of enterprise solutions for managing and validating content entering organizations from various sources. Whether originating from mobile, electronic, paper or other sources, TIS solutions deliver the content to applications that drive the organization.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext